Table 6:
Mean changes in productivity loss stratified across ordinal post-treatment differences in SNOT-22 symptom domain scores for participants electing ESS (n=163)
| ← Worsening Improvements → | SNOT-22 symptom domain score differences: | Rhinologic Symptom Domain | Extra-nasal rhinologic symptom domain | Ear / facial symptom domain | Psychological dysfunction domain | Sleep dysfunction domain |
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | ||
| −31 to −35 | ---- | ---- | ---- | −$8,625 [±$7,507] | ---- | |
| −26 to −30 | −$9,691 [±$415] | ---- | ---- | N/A | ---- | |
| −21 to −25 | −$6,291 [±$6,767] | ---- | N/A | −$2,994 [±$4,135] | −$4,507 [±$6,206] | |
| −16 to −20 | −$3,354 [±$6,867] | ---- | −$4,360 [±$8,712] | −$9,517 [±$15,033] | −$5,958 [±$7,369] | |
| −11 to −15 | −$6,428 [±$18,861] | −$5,702 [±$9,605] | −$1,271 [±$10,633] | −$5,703 [±$8,716] | −$8,935 [±$21,981] | |
| −6 to −10 | −$2,789 [±$9,357] | −$4,777 [±$11,751] | −$4,647 [±$6,612] | −$6,261 [±$19,036] | −$7,129 [±$13,097] | |
| −5 to 0 | −$7,024 [±$12,818] | −$5,089 [±$13,894] | −$6,285 [±$15,630] | −$3,561 [$8,070] | −$1,710 [±$8,167] | |
| 1 to 5 | −$2,715 [±$8,196] | −$4,272 [±$9,442] | −$2,216 [±6,789] | $669 [±$10,351] | −$4,524 [±$8,374] | |
| 6 to 10 | −$8,287 [±$12,499] | −$10,254 [±$16,936] | −$12,544 [±$13,100] | −$7,196 [±$10,252] | −$1,913 [±$9,445] | |
| 11 to 15 | N/A | N/A | N/A | $4,452 [±$5,672] | −$10,394 [±$16,799] | |
| 16 to 20 | N/A | ---- | N/A | N/A | N/A | |
| 21 to 25 | N/A | ---- | N/A | N/A | N/A | |
| 26 to 30 | N/A | ---- | ---- | N/A | ---- | |
| 31 to 35 | ---- | ---- | --- | N/A | ---- |
SD, standard deviation; SNOT-22, 22-item SinoNasal Outcome Test. Negative mean values reflect a post-treatment reduction monetized productivity losses. Positive mean values reflect a post-treatment increase in monetized productivity loss. N/A, no data available within the possible range of scale responses. ESS, endoscopic sinus surgery.